Quantcast

Industry news that matters to you.  Learn more

Mayo Medical Laboratories and Atherotech Diagnostics Lab to Offer Critical Diagnostics’ ST2 Test

Reading time: 1 – 2 minutes

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, today announced that two major reference laboratories — Mayo Medical Laboratories and Atherotech Diagnostics Lab — will offer the company’s Presage ST2 test. The Presage ST2 Assay was recently cleared by the U.S. Food and Drug Administration for use in assessing the prognosis of patients diagnosed with chronic heart failure.

“We are very pleased that Mayo and Atherotech have joined Health Diagnostic Laboratory and ARUP Laboratories in offering the Presage ST2 Assay to its laboratory customers and physicians,” says James Snider, President of Critical Diagnostics. “These are fine organizations that we are proud to be associated with.”

Mayo Medical Laboratories is a global reference laboratory operating within Mayo Clinic’s Department of Laboratory Medicine and Pathology. Backed by the resources of Mayo Clinic, Mayo Medical Laboratories, Mayo Clinic’s Department of Laboratory Medicine and Pathology performs nearly 20 million tests annually.

Atherotech, a privately held cardio-diagnostic company located in Birmingham, Alabama provides its unique testing services to physicians, hospitals, clinics, and other laboratories throughout the United States.

Source: Critical Diagnostics